Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

72.52
-1.2550-1.70%
Volume:1.08M
Turnover:79.65M
Market Cap:10.08B
PE:-10.10
High:74.65
Open:73.51
Low:72.34
Close:73.77
52wk High:88.31
52wk Low:47.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.71
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-58.11
PE(LYR):-11.09

Loading ...

Cytokinetics announces annual stockholders meeting

Reuters
·
May 21

Cytokinetics to Hold Annual Meeting of Stockholders

THOMSON REUTERS
·
May 21

How New Aficamten Phase 3 Data and Equity Raise Will Impact Cytokinetics (CYTK) Investors

Simply Wall St.
·
May 19

Cytokinetics Initiated at Buy by Citigroup

Dow Jones
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

Cytokinetics initiated with a Buy, named a top pick at Citi

TIPRANKS
·
May 19

Cytokinetics grants 20,807 stock options at USD 75.85 under inducement plan

Reuters
·
May 19

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
May 19

Morgan Stanley Sticks to Its Buy Rating for Cytokinetics (CYTK)

TIPRANKS
·
May 18

Major Insider Move Rocks Cytokinetics Investors

TIPRANKS
·
May 15

Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)

GlobeNewswire
·
May 14

Cytokinetics management participates in RBC Capital Markets Global Healthcare Conference fireside chat

Reuters
·
May 13

Cytokinetics Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Cytokinetics says aficamten beats metoprolol in Phase 3 MAPLE-HCM analysis

Reuters
·
May 11

Cytokinetics Announces New Data Related to Myqorzo® (Aficamten) at Esc Heart Failure 2026

THOMSON REUTERS
·
May 11

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

GlobeNewswire
·
May 11

Cytokinetics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 11

Cytokinetics Raises $760 Million in Stock Offering

TIPRANKS
·
May 09